Puma Biotechnology Inc (NASDAQ:PBYI)
| 4.24 Delayed Data As of 3:59pm ET |  +0.02 / +0.47%Today’s Change | 1.60 Today|||52-Week Range 5.16 | +0.24% Year-to-Date |
Latest PBYI News | Press Releases
No recent news for Puma Biotechnology Inc.
Today’s Trading
| Previous close | 4.22 |
| Today’s open | 4.39 |
| Day’s range | 4.24 - 4.49 |
| Volume | 12,841 |
| Average volume (3 months) | 317,022 |
| Market cap | $200.5M |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +52.72% |
| Earnings growth (this year) | +124.94% |
| Earnings growth (next 5 years) | +28.47% |
| Revenue growth (last year) | +12.46% |
| P/E ratio | 18.3 |
| Price/Sales | 0.49 |
| Price/Book | -- |
Competitors
| ---- | ||
| GNFTGenfit SA | 0.00 | 0.00% |
| ASRTAssertio Holdings In... | -0.00 | -0.12% |
| YMABY-mAbs Therapeutics ... | -0.10 | -2.20% |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | March 2, 2023 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $253.2M |
| Annual profit (last year) | -$29.1M |
| Net profit margin | -11.51% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
